Drugs / Superfect
last change Jan 2022 re-read 2 minutes ago

Superfect

Developed for
female infertility · polycystic ovary syndrome
Investigated by
Tehran University of Medical Sciences

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05189873 Jun 2021 → Jan 2022 female infertility, polycystic ovary syndrome Tehran University of Medical Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Superfect “0.5 cc of Superfect is injected daily and vaginal ultrasound is performed 10-14 days later If the endometrial thickness is less than 5 mm and there are no ovarian cysts,...” NCT05189873